尼群地平 T0119
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 39562-70-4 | ¥2,720.00 | 询底价 |
25 mg | 39562-70-4 | ¥355.00 | 询底价 |
50 mg | 39562-70-4 | ¥638.00 | 询底价 |
100 mg | 39562-70-4 | ¥977.00 | 询底价 |
1 g | 39562-70-4 | ¥3,970.00 | 询底价 |
1 mL | 39562-70-4 | ¥355.00 | 询底价 |
200 mg | 39562-70-4 | ¥1,490.00 | 询底价 |
10 mg | 39562-70-4 | ¥225.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Nitrendipine
描述: Nitrendipine (BAY-E-5009) 是 Nifedipine 的类似物,是一种钙通道阻滞剂,具有显着的血管扩张作用。它是一种有效的抗高血压药且不会降低肾小球滤过率,并且具有轻微的利钠作用。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 45 mg/mL (124.88 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
关键字: Inhibitor | calcium | vasculature | hypertension | Autophagy | BAY-E 5009 | Ca channels | dilator | antihypertensive | Nitrendipine | Calcium Channel | peripheral | BAY-E5009 | inhibit | channel | Ca2+ channels
相关产品: Fasudil | DS16570511 | GV-58 | Dantrolene sodium | PD 0299685 | Levamlodipine besylate | Ser-Ala-alloresact acetate | Palonidipine | Suvecaltamide | Dihydroisotanshinone I
相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | ReFRAME Related Library | Calcium Channel Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Orally Active Compound Library | Bioactive Compound Library
尼群地平 T0119信息由TargetMol中国为您提供,如您想了解更多关于尼群地平 T0119报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途